Table 1.

Antibacterial activity of biosynthesized silver nanoparticles using disc diffusion assay.

Bacterial strains	Zone of inhibition (mm)
	BO-AgNP	Control
Bacteroides fragilis	9.43 ± 0.40	9.56 ± 0.30
Streptococcus pneumoniae	10.33 ± 0.57	11.00 ± 0.20
Staphylococcus aureus	10.1 ± 0.17	10.78 ± 0.11
Klebsiella pneumoniae	10.0 ± 0.50	11.00 ± 0.20
Escherichia coli	10.0 ± 1.00	10.8 ± 0.50
Enterococcus faecalis	11.16 ± 0.28	11.45 ± 0.15
Proteus mirabilis	11.33 ± 0.57	12.00 ± 0.25
Pseudomonas aeruginosa	12.0 ± 0.20	12.5 ± 0.15
Staphylococcus epidermidis	14.33 ± 0.57	14.59 ± 0.67